Cerebral oxygen and glucose metabolism and blood flow in mitochondrial encephalomyopathy: a PET study
Creators
- 1. Department of Radiology, Fukushima Medical College, 1 Hikarigaoka, Fukushima-city 960-12 (Japan)
- 2. Department of Radiology and Nuclear Medicine, Research Institute for Brain and Blood Vessels-Akita, 6-10 Senshukubota-machi, Akita-city 010 (Japan)
- 3. Department of Neurology, Research Institute for Brain and Blood Vessels-Akita, 6-10 Senshukubota-machi, Akita-city 010 (Japan)
Description
Cerebral blood flow (CBF), oxygen metabolism (CMRO2), and glucose metabolism (CMRGlc) were measured using positron emission tomography in five patients diagnosed as having mitochondrial encephalomyopathy. The molar ratio between the oxygen and glucose consumptions was reduced diffusely, as CMRO2 was markedly decreased and CMRGlc was slightly reduced. The CBF showed less changes. The CBF increase on hypercapnia was smaller than normal, though this was not significant. CBF with hypocapnia demonstrated a significant reduction compared with the normal. These results suggest that oxidative metabolism is impaired and anaerobic glycolysis relatively stimulated, due to a primary defect of mitochondrial function, and that mild lactic acidosis occurs in brain tissue because of impaired utilisation of pyruvate in the TCA cycle. As these findings appear to indicate directly a characteristic of this disease, such measurements may be a useful tool for assessment of the pathophysiology and for diagnosis of mitochondrial encephalomyopathy. (orig.). With 1 fig., 4 tabs
Additional details
Publishing Information
- Journal Title
- Neuroradiology
- Journal Volume
- 38
- Journal Issue
- 2
- Journal Page Range
- p. 102-107.
- ISSN
- 0028-3940
- CODEN
- NRDYAB
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 27059655
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BLOOD FLOW; BRAIN; COMPUTERIZED TOMOGRAPHY; FLUORINE 18; FLUORODEOXYGLUCOSE; GLUCOSE; METABOLISM; MITOCHONDRIA; OXYGEN; OXYGEN 15; PATHOLOGICAL CHANGES; PATIENTS; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS
- Descriptors DEC
- ALDEHYDES; ANIMALS; ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; CARBOHYDRATES; CELL CONSTITUENTS; CENTRAL NERVOUS SYSTEM; DISEASES; DRUGS; ELEMENTS; EMISSION COMPUTED TOMOGRAPHY; EVEN-ODD NUCLEI; FLUORINE ISOTOPES; HEXOSES; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MAMMALS; MAN; MATERIALS; MINUTES LIVING RADIOISOTOPES; MONOSACCHARIDES; NANOSEC LIVING RADIOISOTOPES; NERVOUS SYSTEM; NONMETALS; NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; ORGANS; OXYGEN ISOTOPES; PRIMATES; RADIOACTIVE MATERIALS; RADIOISOTOPES; SACCHARIDES; TOMOGRAPHY; VERTEBRATES